Skip to main content
OpenTrials

Clinical trial condition

Telangiectasia, Hereditary Hemorrhagic

Explore clinical trials studying Telangiectasia, Hereditary Hemorrhagic. Study availability and eligibility vary by location and protocol.

19 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Telangiectasia, Hereditary Hemorrhagic trial results

Completed

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.

NCT03954782

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations
  • CHU d'Angers Angers, France
  • Hôpital Femme-Mère-Enfant-Centre de Référence pour la maladie de Rendu-Osler Bron, France
  • CHU Clermont Ferrand Clermont-Ferrand, France
  • CHU de Marseille-Hôpital la conception Marseille, France
View Trial Details
Completed

Pomalidomide for the Treatment of Bleeding in HHT

NCT03910244

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCSD Hemophilia and Thrombosis Treatment Center San Diego, California, United States
  • UCSF Outpatient Hematology Clinic San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
View all 14 locations
View Trial Details

Related conditions